Callisto CEO Dr. Gary S. Jacob Releases Letter to Shareholders ...
Submitted by admin on Tue, 2006-04-11 22:00.
Callisto CEO Dr. Gary S. Jacob Releases Letter to Shareholders; CEO Affirms Commitment to Continued Aggressive Development of Clinical Programs with Atiprimod and L-Annamycin Anti-cancer
This is cache, read story here